Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients

Frerichs, KA; Verkleij, CPM; Dimopoulos, MA; Soto, JAM; Zweegman, S; Young, MH; Newhall, KJ; Mutis, T; van de Donk, NWCJ

van de Donk, NWCJ (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Canc Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands.

CANCERS, 2021; 13 (10):

Abstract

Simple Summary The CD38-targeting antibody daratumumab has marked activity in multiple myeloma through direct anti-tumor effects and immunomodulatory ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索